Health-Related Quality of Life (HRQoL) and Changes in Work Productivity Measures with Subcutaneous C1-Inhibitor [C1-INH(SC)] for the Prevention of Hereditary Angioedema (HAE) Attacks: Findings from the Compact Study

被引：1
|
作者：
Lumry, William [1 ]
Craig, Timothy J. [2 ]
Farkas, Henriette [3 ]
Feuersenger, Henrike [4 ,5 ]
机构：
[1] AARA Res Ctr, Dallas, TX USA
[2] Penn State Univ, Hershey Med Ctr, Hershey, PA USA
[3] Semmelweis Univ, Budapest, Hungary
[4] CSL Behring, Marburg, Germany
[5] CSL Behring, King Of Prussia, PA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2016.12.751
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
732
引用
收藏
页码：AB233 / AB233
页数：1
相关论文
共 50 条
  • [41] RESPONSE TO SUBCUTANEOUS C1-ESTERASE INHIBITOR (C1-INH [SC]), A PROPHYLACTIC TREATMENT FOR ADOLESCENTS AND ADULTS WITH HEREDITARY ANGIOEDEMA: RESULTS FROM THE PHASE 3 COMPACT TRIAL
    Gower, Richard
    Li, H. Henry
    Levy, Donald Sheldon
    Jacobs, Iris
    JOURNAL OF ADOLESCENT HEALTH, 2018, 62 (02) : S5 - S6
  • [42] Patients With Severe Hereditary Angioedema Treated With Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) to Reduce the Incidence and Severity of Attacks: Results From a Phase 3 Trial
    Gower, Richard G.
    Li, Henry
    Levy, Donald
    Jacobs, Iris
    PEDIATRICS, 2018, 142
  • [43] Time to effect of fixed-dose subcutaneous (SC) C1 inhibitor liquid for prophylactic treatment of hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE): results from the phase 3 SAHARA study
    Riedl, M. A.
    Johnston, D. T.
    Tang, T.
    Vardi, M.
    Bernstein, J. A.
    ALLERGY, 2018, 73 : 288 - 288
  • [44] Exploring the Quality of Life Benefits of Subcutaneous C1-Inhibitor (C1-INH) Replacement Therapy Using Qualitative Research Methods
    Anderson, John T.
    Levy, Donald S.
    Lumry, William R.
    Koochaki, Patricia
    Lanar, Sally
    Li, H. Henry
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB45 - AB45
  • [45] Health-related quality of life (HRQoL) in patients with hereditary angioedema (HAE) receiving nanofiltered C1 inhibitor (C1 INH-nf) for prophylaxis: results of a randomised, placebo-controlled, cross-over study
    Lumry, W. R.
    Miller, D. P.
    Beusterien, K.
    Hautamaki, E.
    Fitts, D.
    Dayno, J.
    ALLERGY, 2014, 69 : 491 - 491
  • [46] Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
    Craig, Timothy
    Zuraw, Bruce
    Longhurst, Hilary
    Cicardi, Marco
    Bork, Konrad
    Grattan, Clive
    Katelaris, Constance
    Sussman, Gordon
    Keith, Paul K.
    Yang, William
    Hebert, Jacques
    Hanzlikova, Jana
    Staubach-Renz, Petra
    Martinez-Saguer, Inmaculada
    Magerl, Markus
    Aygoren-Pursun, Emel
    Farkas, Henriette
    Reshef, Avner
    Kivity, Shmuel
    Neri, Sergio
    Crisan, Ioana
    Caballero, Teresa
    Baeza, Maria L.
    Dolores Hernandez, Maria
    Li, Henry
    Lumry, William
    Bernstein, Jonathan A.
    Hussain, Iftikar
    Anderson, John
    Schwartz, Lawrence B.
    Jacobs, Joshua
    Manning, Michael
    Levy, Donald
    Riedl, Marc
    Christiansen, Sandra
    Feuersenger, Henrike
    Pragst, Ingo
    Mycroft, Sarah
    Pawaskar, Dipti
    Jacobs, Iris
    Zuraw, Bruce L.
    Cicardi, Marco
    Craig, Timothy
    Longhurst, Hilary
    Grattan, Clive
    Grattan, Clive
    Bork, Konrad
    Kreuz, Wolfhart
    Jacobs, Iris
    Pragst, Ingo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06): : 1793 - +
  • [47] Impact of C1-INH(SC) on Type I/II Hereditary Angioedema: Findings from a US Patient Survey
    Tachdjian, Raffi
    Taqi, Mahdi
    Riley, Daniel
    Krishnarajah, Girishanthy
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB48 - AB48
  • [48] A MODELLED ECONOMIC EVALUATION OF FIRAZYR® (ICATIBANT) FOR SYMPTOMATIC TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) IN ADULTS WITH C1-ESTERASE-INHIBITOR (C1-INH) DEFICIENCY
    Tilden, D.
    Cottrell, S.
    Tocchini, L.
    Jayaram, N.
    Sinani, R.
    Barnes, D.
    VALUE IN HEALTH, 2011, 14 (07) : A322 - A323
  • [49] On Demand Therapy in Hereditary Angioedema with C1 Inhibitor Deficiency (C1-INH-HAE): Prospective Observational Study of 4244 Attacks
    Mansi, Marta
    Zanichelli, Andrea
    Periti, Giulia
    Azin, Giulia M.
    Casazza, Giovanni
    Vacchini, Romualdo
    Coerezza, Anna
    Suffritti, Chiara
    Cicardi, Marco
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB385 - AB385
  • [50] Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial
    Li, H. Henry
    Mycroft, Sarah
    Christiansen, Sandra
    Wood, Daniel N.
    Feuersenger, Henrike
    Pawaskar, Dipti
    Jacobs, Iris
    ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (05) : 365 - 370
12345